Amyris and DSM close US$50M strategic transaction on farnesene supply

The deal licenses DSM rights to assume the supply of farnesene to Givaudan

Related Articles

A woman stands next to a bunch of servers while checking her laptop.

NUTRITION & HEALTH NEWS

05 Feb 2024 --- Digitalization, next-generation technologies and scientific advancements are set to shake up the supplement and nutraceutical industry in the coming... Read More

small vials of perfumes being tested with strip of paper

BUSINESS NEWS

26 Jan 2024 --- Givaudan beat sales estimates, with 2023 sales rising 4.1% to CHF 6.9 billion (US$8 billion). The company says price increases helped offset rising raw... Read More

Worker in a factory doing a quality control test.

NUTRITION & HEALTH NEWS

05 Jan 2024 --- This week in nutrition news, Reckitt/Mead Johnson Nutrition recalled several batches of an infant formula powder product after a sample tested positive... Read More

A person games in a competition.

NUTRITION & HEALTH NEWS

02 Nov 2023 --- As esports continues to increase in worldwide popularity, the nutrition industry is adapting, innovating and looking at the benefits of both novel and... Read More

Woman facing right in a lab holding a beaker.

BUSINESS NEWS

13 Oct 2023 --- For the first nine months of the year, fragrance and flavors manufacturer Givaudan has made sales of CHF5,265 million (US$5,591 million), an increase of... Read More

trans